Choriocapillaris Activation in Macular Degeneration
Choriocapillaris Activation in Macular Degeneration
批准号:
7495509
负责人:
Robert Foster Mullins
金额:
$36.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-15 至 2012-07-31
关键词:
AffectAgeAge related macular degenerationAnaphylatoxinAnaphylatoxinsAreaBehaviorBiochemistryBioinformaticsBlindnessBlood VesselsCandidate Disease GeneCell Surface ProteinsCellsChoroidComplementComplement 3aComplement 5aComplexComputersCultured CellsDevelopmentDiseaseElderlyEndothelial CellsEngineeringEventExposure toEyeGenesGeneticGenetic PolymorphismGenotypeGenotype SummaryGrantGrowthHumanImmunohistochemistryIn VitroInfiltrationInflammationInjuryLeukocytesMacular degenerationMediatingMessenger RNAMethodologyMicroarray AnalysisMicroscopyMissionMolecularMutationNational Eye InstituteNatureOrgan Culture TechniquesPathogenesisPatientsPatternPlayPolymerase Chain ReactionPopulationPrevalenceProteinsReverse Transcriptase Polymerase Chain ReactionRiskRoleScreening procedureSingle Nucleotide PolymorphismSocietiesSystemTestingTimeTissuesTranscriptVisionVision researchWestern BlottingWestern Worldcohortfollow-upimmunocytochemistryresearch studyresponse
中文摘要
产品说明:视网膜相关性黄斑变性(AMD)是西方世界无法治愈的失明的主要原因,仅在美国就有数百万人受到影响。随着人口老龄化,AMD对社会的负面影响将增加。不幸的是,AMD的发病机制目前知之甚少。由于AMD的流行及其对视力的严重损害,评估AMD的疾病机制是国家眼科研究所的使命的一部分,并在2004年国家眼科和视力研究计划中得到强调。
在这个项目中,我们将研究脉络膜毛细血管激活分子在AMD中的作用。鉴于炎症和补体系统在AMD中的作用,我们建议探讨脉络膜毛细血管内皮细胞的激活可能是这种疾病的发病机制中的中心事件的假设。
该项目的第一个具体目标是检查正常眼睛和AMD眼睛中内皮细胞活化的程度和性质。将对正常眼、早期AMD眼和晚期AMD眼进行持续的分子和组织学研究。
在第二个具体目标中,我们将确定内皮细胞是否在暴露于可能发生在AMD中的微环境损伤后在培养物中被激活。将用补体复合物(使用我们开发的方法)和补体副产物(过敏毒素)挑战内皮细胞培养物。将使用微阵列、免疫细胞化学、真实的时间PCR和Western印迹来研究这些细胞的活化反应。
在第三个具体目标中,我们将使用生物信息学驱动的方法来检验编码内皮激活分子的基因中的突变或多态性与AMD相关的假设。将在30个候选基因中筛选单核苷酸多态性(每年资助6个)。将使用免疫组织化学和人眼睛的蛋白质印迹法对遗传发现进行随访,以检查特定基因型的可能功能后果。
总结:组成血管的内皮细胞可能在AMD中发挥重要作用。这些细胞促进炎症的一种方式是吸引白色血细胞进入发炎组织。内皮细胞通过表达在内皮“活化”过程中丰度增加的细胞表面蛋白来发挥这一作用。我们推测,在这种疾病中,眼内内皮细胞活化是导致组织损伤和异常血管生长的原因。涉及遗传学、计算机工程、生物化学、细胞培养和显微镜的跨学科实验有望提供关于脉络膜毛细血管激活在AMD发展中的潜在作用的新信息。
英文摘要
DESCRIPTION: Age-related macular degeneration (AMD) is the leading cause of untreatable blindness in the Western world, with millions affected in the U.S. alone. As the population ages, the negative impact of AMD on society will increase. Unfortunately, the pathogenesis of AMD is currently poorly understood. Because of the prevalence of AMD, and its severe toll on vision, evaluating disease mechanisms in AMD is part of the mission of the National Eye Institute and is highlighted in the 2004 National Plan for Eye and Vision Research.
In this project we will examine the role of choriocapillaris activation molecules in AMD. In view of the role of inflammation and the complement system in AMD, we propose to explore the hypothesis that activation of choriocapillaris endothelial cells may be a central event in the pathogenesis of this disease.
The first specific aim of this project is to examine the extent and nature of endothelial cell activation in normal eyes and eyes with AMD. Ongoing molecular and histological studies will be performed on normal eyes, early AMD eyes, and advanced AMD eyes.
In the second specific aim we will determine whether endothelial cells become activated in culture following exposure to microenvironmental insults that are likely to occur in AMD. Endothelial cell cultures will be challenged with complement complexes (using methodology we have developed) and complement byproducts (anaphylatoxins). The activation response of these cells will be studied using microarrays, immunocytochemistry, real time PCR and Western blotting.
In the third specific aim we will test the hypothesis that mutations or polymorphisms in the genes encoding endothelial activation molecules are associated with AMD using a bioinformatics-driven approach. Single nucleotide polymorphisms will be screened in 30 candidate genes (6 per year of the grant). Genetic findings will be followed up using immunohistochemistry and Western blotting of human eyes to examine the possible functional consequences of specific genotypes.
Summary: The endothelial cells that comprise blood vessels are likely to play an important role in AMD. One way that these cells promote inflammation is by attracting white blood cells into the inflamed tissue. Endothelial cells perform this role through expression of cell surface proteins that increase in abundance during endothelial "activation". We hypothesize that endothelial cell activation in the eye is responsible for the tissue injury and abnormal blood vessel growth in this disease. Interdisciplinary experiments involving genetics, computer engineering, biochemistry, cell culture and microscopy are expected to provide new information about the potential role of choriocapillaris activation in the development of AMD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Studies of the Choriocapillaris in AMD
-
批准号:10338267
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Robert Foster Mullins
-
依托单位:
Molecular Studies of the Choriocapillaris in AMD
-
批准号:10541173
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Robert Foster Mullins
-
依托单位:
A Next Generation Outer Retinal Microphysiological System
-
批准号:10614641
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Robert Foster Mullins
-
依托单位:
A Next Generation Outer Retinal Microphysiological System
-
批准号:10444742
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2022
-
负责人:Robert Foster Mullins
-
依托单位:
Molecular Imaging Core
-
批准号:10663390
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2016
-
负责人:Robert Foster Mullins
-
依托单位:
Molecular Imaging Core
-
批准号:10488230
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2016
-
负责人:Robert Foster Mullins
-
依托单位:
Molecular Imaging Core
-
批准号:10271730
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2016
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris protection and replacement in AMD
-
批准号:10397546
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Protection and Replacement in AMD
-
批准号:8752902
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Protection and Replacement in AMD
-
批准号:8895955
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris protection and replacement in AMD
-
批准号:9920151
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Protection and Replacement in AMD
-
批准号:10734878
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2014
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Activation in Macular Degeneration
-
批准号:8118503
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2007
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Activation in Macular Degeneration
-
批准号:7318536
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2007
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Activation in Macular Degeneration
-
批准号:7665360
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2007
-
负责人:Robert Foster Mullins
-
依托单位:
Choriocapillaris Activation in Macular Degeneration
-
批准号:7905688
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2007
-
负责人:Robert Foster Mullins
-
依托单位:
The Choriocapillaris in Aging and Macular Disease
-
批准号:6734677
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2003
-
负责人:Robert Foster Mullins
-
依托单位:
The Choriocapillaris in Aging and Macular Disease
-
批准号:6597402
-
项目类别:
-
资助金额:$14.74万
-
财政年份:2003
-
负责人:Robert Foster Mullins
-
依托单位:
The Choriocapillaris in Aging and Macular Disease
-
批准号:6888050
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2003
-
负责人:Robert Foster Mullins
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: